Informing Decisions,
Improving Care
Des O'Leary became Chief Executive Officer of OncoMark in July 2015. He has over 20 years’ experience in the Diagnostics industry with both early stage start-ups and international Corporations. He was Chief Operating Officer and Executive Director of Biotrin International from its establishment in the early 1990's through to its acquisition by Diasorin Corporation in 2008.
Prof. William (Liam) M. Gallagher is co-founder and Chief Scientific Officer of OncoMark. He is currently the Director of the University College Dublin (UCD) Conway Institute of Biomolecular and Biomedical Research, where he also holds an academic post as Professor of Cancer Biology. From September 2009 - August 2011 Liam was the Vice-Principal for Research and Innovation within the UCD College of Life Sciences.
Donal O'Shea is an experienced corporate officer in the technology and diagnostics sectors, having business leadership experience from start-up through to large corporate enterprise. He is an innovator with a proven track record in developing products from concept to market. Donal holds a Degree and Ph.D. in Biotechnology from Dublin City University, where he was also a member of the academic staff in the School of Biotechnology from 1999 to 2009.
Cormac Kilty has over 30 years experience in the Diagnostic and Biomarker Industry. He holds a PhD in Zoology and Biochemistry from University College Dublin. Early in his career he served as the Head of the European Research and Development Group for Baxter Healthcare. He has been a founder of a number of companies including Biotrin International, Opsonsa Therapeutics and Argutus Medical.
Mr Stephen Penney is co-founder of OncoMark and a chartered accountant with over 22 years’ international financial services and consultancy experience. He is a Fellow of Chartered Accountants Ireland and also holds a BSc (Hons) in Biotechnology from Dublin City University.